Immunomodulation

Immunomodulation

H. Hugh Fudenberg

65,43 €
IVA incluido
Disponible
Editorial:
Springer Nature B.V.
Año de edición:
2012
Materia
Inmunología
ISBN:
9781461593607
65,43 €
IVA incluido
Disponible

Selecciona una librería:

  • Librería Samer Atenea
  • Librería Aciertas (Toledo)
  • Kálamo Books
  • Librería Perelló (Valencia)
  • Librería Elías (Asturias)
  • Donde los libros
  • Librería Kolima (Madrid)
  • Librería Proteo (Málaga)

On May 14-16, 1982, a group of scientists met in Viareggio, Italy to present ideas, and exchange relevant data on current approaches on immunomodulators. We felt that the embodiment of the substance of that international symposium into this volume will be beneficial in keeping both clinicians and basic scientists abreast of the latest exciting developments in this rapidly accelerating field. We hope that the publication of this series of papers by an international panel of experts will enhance the nature of future inves t igat ive stud ies with such ent it ies . Under the rubric of immunology, it is obvious that such a term as 'immunomodulation' could be construed as being all encompassing. However, it is intriguing that the immune modulators touched on in these sessions can be subcategorized into about five broad groups. Almost all substances, excepting those entities that are immuno­ logically inert, will have some modulating effects on immunity. From the coarse adjustment of antibody feedback inhibition upon cellular limnunity to the subtle finesse envisioned in Jerne’s idiotypic network and s’lppressor T cells, immunomodulators attempt to either magnify or diminish those responses that are normally elicited by antigen. The broad groups - thymic hormones, D.L.E., Interferon, drugs, and the use of bacterial products appear to be at the forefront of much of the pioneering work on immunomodulation.

Artículos relacionados

  • MONOCLONAL ANTIBODIES
    Fathimunisa Begum
    This book offers a comprehensive exploration of the groundbreaking use of monoclonal antibody drugs in modern medicine. Beginning with an insightful introduction to monoclonal antibodies, the book delves into the intricate process of their production, from immunization and hybridoma cell preservation to large-scale antibody manufacturing.In its captivating pages, readers will d...
    Disponible

    28,64 €

  • Everybody’s Antibodies
    Jr. Mark P. Friedlander
    In our daily lives, we are surrounded by countless germs that often go unnoticed, thanks to the remarkable defense mechanism within us known as the immune system. Curiously, this intricate network of tiny components remains one of the least understood aspects of our body’s organization. However, with the advent of COVID-19, our collective immune systems have faced an extraordin...
    Disponible

    10,18 €

  • INTRODUCTION TO AUTONOMIC MEDICINE
    David S Goldstein
    Autonomic medicine is emerging across the globe as an important subspecialty in healthcare. The overwhelming majority of medicine today is based on the assumption that a patient’s autonomic nervous system is intact and functioning normally. But what if it is not? What do we do when there are abnormalities in the regulatory functions of the body, such as maintaining normal blood...
  • Antibody Engineering
    Borrebaeck
    ...
    Disponible

    141,84 €

  • In Defense of Self
    William R. Clark
    ...
    Disponible

    27,64 €

  • Global Virology IV
    In the face of recent viral outbreaks and a global viral pandemic, the necessity for innovation and continued rapid advancement in viral diagnosis and treatment methods has become even more apparent. Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century explores the latest advances in virology and trends in clinical practice, focused on foundati...

Otros libros del autor

  • Biomedical Institutions, Biomedical Funding, and Public Policy
    H. Hugh Fudenberg
    The world is on the threshold of a great new industrial revolution, a 1 scientific-industrial revolution. Recombinant DNA technology and hybridoma technology ('monoclonal antibodies') have already pro­ vided unique investment opportunities for venture capitalists. Hence published reports of biomedical research are no longer restricted to scientific jo...
    Disponible

    66,53 €